TXG News and Press, 10x Genomics Inc. From 09/19/23

2023-09-19 10:11:41 ET More on NanoString, 10x Genomics Seeking Alpha’s Quant Rating on NanoString 10x Genomics: Recent Performance Amplifies My Bullish Conviction NanoString gains amid new counterclaims in patent dispute with 10x Genomics NanoString T...

10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit PR Newswire Strengthen cellular analysis with cost-efficient multiomic readouts and streamlined workflows PLEASANTON, Calif. , Sept. 14, 2023 /PRNewswire/ ...

2023-09-08 10:46:39 ET Summary 10x Genomics reported impressive Q2 performance with revenue growing by 28% YoY to reach $147M. The company's growth is driven by strong performance in both single-cell and spatial biology portfolios. Despite challenges in the Chinese market and ...

TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) is pleased to report initial results from the 2023 drilling program at EPO, a deposit located to the north of the Media Luna deposit, in close proximity to the G...

Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others PR Newswire Researchers uncover mechanisms behind divergent responses to immune checkpoint blockade between primary and metastat...

10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference PR Newswire PLEASANTON, Calif. , Aug. 30, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of it...

10x Genomics Surpasses 100 Xenium Analyzer Shipments PR Newswire Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale PLEASANTON, Calif. , Aug. 29, 2023 /PRNewswire...

2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...

2023-08-03 22:28:06 ET 10X Genomics, Inc. (TXG) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 ET Company Participants Cassie Corneau - Manager, IR and Strategic Finance Serge Saxonov - Co-Founder, CEO & Director Justin McAnear - CFO Conference...

2023-08-03 16:37:36 ET 10x Genomics press release ( NASDAQ: TXG ): Q2 GAAP EPS of -$0.53. Revenue of $146.8M (+28.1% Y/Y). Cash and cash equivalents and marketable securities were $391.4 million as of June 30, 2023. 10x Genomics is raising its full year 2023 r...